衛濤

衛濤，男，教授，碩士生導師，溫州醫科大學藥學院黨委委員、副院長。

基本介紹

• 中文名：衛濤
• 學位/學歷：博士
• 職稱：教授

研究方向

1.抗腫瘤藥物設計、合成、藥理活性研究

教育經歷

1998.09–2002.7 吉林化工學院，獲學士學位，環境工程專業

2002.09–2005.05 東南大學，獲碩士學位，材料物理與化學專業

2010.09-2015.05 南京理工大學，獲博士學位，物理化學專業

工作經歷

1.2005.08-至今，溫州醫科大學藥學院，教授，黨委委員、副院長

科研項目

1.浙江省自然基金：新型螺雜環異構體FGFR1抑制劑的設計、反應機理、合成及抗腫瘤活性研究，項目承擔人，2012.1~2014.12，項目編號：LY12H30005，已結題

2.溫州市科技局資助項目：異黃酮類藥物分子設計的理論研究。項目承擔人，起止時間：2009.3-2011.12，項目編號：Y20090101，已結題

3.參與國家自然基金：非ATP競爭性的IKK-β抑制劑的設計發現及其藥理活性研究，2014.1-2014.12，已結題

4.參與浙江省醫藥衛生科技計畫項目（2010QNA015），項目名稱：rh-bFGF對帕金森實驗動物神經遞質通路的調節及分子機制研究，起止年月：2010年06月-2012年07月，排名第二，已結題

5.參與國家自然基金：萘甲酸鹽類離子液體對β-雙酮類抗生素配合物的強螢光增敏機理與分析套用，項目編號：21377100，已結題

6.參與浙江省醫藥衛生科技計畫項目（2010QNA015），項目名稱：rh-bFGF對帕金森實驗動物神經遞質通路的調節及分子機制研究，起止年月：2010年06月-2012年07月，排名第二，已結題

7.參與國家自然基金：萘甲酸鹽類離子液體對β-雙酮類抗生素配合物的強螢光增敏機理與分析套用，項目編號：21377100，已結題

代表性論著

1.Yuqiao Wang*, Wei Wang, Shasha Wang, Wenjing Chu, Tao Wei*, Haijun Tao,Chuanxiang Zhang, Yueming Sun. Enhanced photoelectrochemical detection of L-ysteine based on the ultrathin polythiophene layer sensitized anatase TiO2 on F-doped tin oxide substrates[J]. Sensors and Actuators B: Chemical, 232 (2016) 448–453.

2.Tao Wei, Weihua Zhu, Jingjing Zhang and Heming Xiao. DFT study on energetic tetrazolo-[1,5-b]-1,2,4,5-tetrazine and 1,2,4-triazolo-[4,3-b]-1,2,4,5-tetrazine derivatives，J. of Hazardous Materials，2010, 179 (1-3)：581-590.

3.Jianzhang Wu*，Jiansong Ji*，Bixia Weng，Peihong Qiu，Karvannan Kanchana，Tao Wei，Yi Wang，Yuepiao Cai，Xiaokun Li，Guang Liang. Discovery of novel non-ATP competitive FGFR1 inhibitors and evaluation of their anti-tumor activity in non-small cell lung cancer in vitro and in vivo. Oncotarget 2014, 5(12):4543-4553.

4.Yi Wang，Yuepiao Cai，Jiansong Ji，Zhiguo Liu，Chengguang Zhao，Yunjie Zhao，Tao Wei，Xueqian Shen，Xiuhua Zhang，Xiaokun Li*，Guang Liang*，Discovery and identification of new non-ATP competitive FGFR1 inhibitors with therapeutic potential on non-small-cell lung cancer. Cancer Letters 2014, 344: 82-89.

5.Wang Yi，Jie Hu，Yuepiao Cai，Shanmei Xu，Bixia Weng，Kesong Peng，Xiaoyan Wei，Tao Wei，Huiping Zhou，Xiaokun Li，Guang Liang*. An Oxygen-Chelate Complex, Palladium Bis-acetylacetonate, Induces Apoptosis in H460 Cells via Endoplasmic Reticulum Stress Pathway Rather than Interacting with DNA. Journal of Medicinal Chemistry 2013, 56: 9601-9611.

6.Tao Wei, Weihua Zhu, Xiaowen Zhang,Yu-Fang Li, and Heming Xiao,Molecular Design of 1,2,4,5-Tetrazine-Based High-Energy Density Materials. J. Phys. Chem. A 2009, 113(33), 9404-9412..

7.Tao Wei, Jianzhang Wu, Weihua Zhu, Chenchen Zhang, Heming Xiao, Characterization of nitrogen-bridged 1,2,4,5-tetrazine-, furazan-, and 1H-tetrazole-based polyheterocyclic compounds: heats of formation, thermal stability, and detonation properties. J. Mol. Model. 2012, 18(8), 3467-3479

8.Wenjing Jia,Wenting Ding,Xinmiao Chen,Zhengwei Xu,Yelin Tang,Meihong Wang,Bin Zheng,Yali Zhang,Tao Wei*,Zaisheng Zhu*.Selenium-Containing Compound AmelioratesLipopolysaccharide-Induced Acute Lung Injury viaRegulating theMAPK/AP-1 Pathway[J].Inflammation, 2021, 44:2518-2530.

9.Jianzhang Wu*，Jiansong Ji*，Bixia Weng，Peihong Qiu，Karvannan Kanchana，Tao Wei，Yi Wang，Yuepiao Cai，Xiaokun Li，Guang Liang. Discovery of novel non-ATP competitive FGFR1 inhibitors and evaluation of their anti-tumor activity in non-small cell lung cancer in vitro and in vivo. Oncotarget 2014, 5(12):4543-4553.

10.Yi Wang，Yuepiao Cai，Jiansong Ji，Zhiguo Liu，Chengguang Zhao，Yunjie Zhao，Tao Wei，Xueqian Shen，Xiuhua Zhang，Xiaokun Li*，Guang Liang*，Discovery and identification of new non-ATP competitive FGFR1 inhibitors with therapeutic potential on non-small-cell lung cancer. Cancer Letters 2014, 344: 82-89.

11.Rong Jin, Qiuxiang Chen, Song Yao, Encheng Bai, Weitao Fu, Ledan Wang, Jiabing Wang, Xiaojing Du,Tao Wei*, Haineng Xu, Chengxi Jiang, Peihong Qiu, Jianzhang Wu*, Wulan Li*, Guang Liang.Synthesis and anti-tumor activity of EF24 analogues as IKKβ inhibitors[J].European Journal of Medicinal Chemistry, 2018,144:218-228..